YOLANDA ROPER: Open Payments
NPI 1508420795 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 18 payments from 12 companies in 2025. Trend: 2023 $487 · 2024 $573 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| SpringWorks Therapeutics, Inc. | 2 | $244 |
| Janssen Biotech, Inc. | 2 | $161 |
| SOBI, INC | 1 | $124 |
| SANOFI-AVENTIS U.S. LLC | 4 | $123 |
| Caris MPI, Inc. | 2 | $43 |
| Astellas Pharma US Inc | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| ARRAY BIOPHARMA INC | 1 | $25 |
| JAZZ PHARMACEUTICALS INC. | 1 | $24 |
Products named: OGSIVEO, RYBREVANT, Vonjo, REZUROCK, MI CANCER SEEK, Vyloy, KEYTRUDA, Enhertu.
Industry payments across FL — which companies pay providers there.
